Article Text

Download PDFPDF
Conservative management of lateral hip pain: the future holds promise
  1. Alison Grimaldi1,2
  1. 1School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Queensland, Australia
  2. 2Physiotec, Tarragindi, Queensland, Australia
  1. Correspondence to Dr Alison Grimaldi, School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, QLD 4072, Australia; info{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

It goes by many names but lateral hip pain, essentially gluteal tendinopathy has a profound impact on quality of life and activity level. Currently, there is little high-level evidence as to how to manage it.

Evidence to date

In the systematic review regarding greater trochanteric pain syndrome (GTPS) Barratt et al1 found only eight non-surgical treatment studies eligible for review. Of these, all but one had a moderate-to-high risk of bias. The strongest evidence, both in terms of study design and outcomes, is for corticosteroid injection (CSI). With pain reduction occurring in the majority of patients within 4 weeks, it is not surprising that CSI is often the first line of treatment in general medical practice. Similar to responses to CSI seen in other tendinopathies however, recurrence is common and success rates fall over time, making this approach no more effective in the longer term than adopting a wait-and-see approach. While acute complications following CSI are rare, concerns remain regarding potential negative effects on the tendon associated with down regulation …

View Full Text


  • Twitter Follow Alison Grimaldi at @alisongrimaldi

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Linked Articles